Expert views on isotretinoin for acne
Part of Skin clinical trials.
This study gathers opinions from experienced dermatologists to create expert guidelines on using isotretinoin for acne. It does not test a new treatment but aims to improve how isotretinoin is prescribed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a board-certified dermatologist or have an equivalent certification.
- You have at least 5 years of experience treating acne after becoming certified.
- You regularly prescribe oral isotretinoin to patients in your practice.
- You are willing to complete all rounds of the Delphi survey.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks experienced dermatologists to share their expert opinions on using a low-dose medication (isotretinoin) for skin rejuvenation. The goal is to see if there is general agreement on how well it works and how to use it safely.
This trial tests whether a guided exercise program helps people taking isotretinoin—a strong acne medication—manage side effects and feel better. If you're starting isotretinoin for the first time and are not currently a regular exerciser, you may be able to join.
This study tests different acne treatments to see how well they work. It may help you manage your acne with a new option.
This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
This trial compares two treatments for nail fungus (onychomycosis): a medication called isotretinoin and a special light therapy (excimer light) used alongside standard care. It aims to find which works better as an add-on treatment.
Hear when a new Isotretinoin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.